Meanwhile, in the low‐risk group, higher proportions of anti‐tumor immune cells, such as T cell CD8+, T cell follicular helper, B cell plasma, T‐cells‐CD4‐memory‐resting, and T cell CD4+ memory activated were observed (Figure 7A). This evidence concerns the gene CD8A and neoplasm.